MiR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells

International Journal of Cancer

Volumn 128, Issue 6, 2011, Pages 1269-1279

  Liu, Ming ^a   Lang, Nan ^a   Qiu, Meng ^a   Xu, Feng ^a   Li, Qiu ^a   Tang, Qiulin ^a   Chen, Ji ^a   Chen, Xi ^a   Zhang, Siyuan ^a   Liu, Zhen ^a   Zhou, Jitao ^a   Zhu, Yajie ^a   Deng, Yu ^a   Zheng, Yi ^b   Bi, Feng ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cdc42; cell cycle; colorectal cancer; miR 137; small G protein

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 137; P21 ACTIVATED KINASE; PROTEIN CDC42; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL INVASION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC CONSERVATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; APOPTOSIS; BLOTTING, WESTERN; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; LUCIFERASES; MICRORNAS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78650539977     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25452     Document Type: Article

References (32)

1. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ,. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-D158.
2. Chi SW, Zang JB, Mele A, Darnell RB,. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009; 460: 479-86.
3. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
4. Lai EC,. MicroRNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363-4.
5. Wu W, Sun M, Zou GM, Chen J,. MicroRNA and cancer: Current status and prospective. Int J Cancer 2007; 120: 953-60.
6. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
7. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H,. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36.
8. Korpal M, Lee ES, Hu G, Kang Y,. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910-4.
9. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E,. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 2009; 125: 1407-13.
10. Li Ma, Julie Teruya-Feldstein, Robert A. Weinberg., Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-8.
11. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM,. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci 2005; 102: 13944-9.
12. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D,. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-9.
13. Etienne-Manneville S, Hall A,. Rho GTPases in cell biology. Nature 2002; 420: 629-35.
14. Sahai E, Marshall CJ,. RHO-GTPases and cancer. Nat Rev Cancer 2002; 2: 133-42.
15. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y, Yoshida K,. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 2004; 10: 4799-805.
16. Gómez Del Pulgar T, Valdés-Mora F, Bandrés E, Pérez-Palacios R, Espina C, Cejas P, García-Cabezas MA, Nistal M, Casado E, González-Barón M, García-Foncillas J, Lacal JC,. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int J Oncol 2008; 33: 185-93.
17. Fritz G, Just I, Kaina B,. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999; 81: 682-7.
18. Abraham MT, Kuriakose MA, Sacks PG, Yee H, Chiriboga L, Bearer EL, Delacure MD,. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001; 111: 1285-9.
19. Tucci MG, Lucarini G, Brancorsini D, Zizzi A, Pugnaloni A, Giacchetti A, Ricotti G, Biagini G,. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br J Dermatol 2007; 157: 1212-6.
20. Hirsch DS, Shen Y, Wu WJ,. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. Cancer Res 2006; 66: 3523-30.
21. Bao W, Thullberg M, Zhang H, Onischenko A, Strömblad S,. Cell attachment to the extracellular matrix induces proteasomal degradation of p21(CIP1) via Cdc42/Rac1 signaling. Mol Cell Biol 2002; 22: 4587-97.
22. Zugasti O, Rul W, Roux P, Peyssonnaux C, Eychene A, Franke TF, Fort P, Hibner U,. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol 2001; 21: 6706-17.
23. Yang L, Wang L, Zheng Y,. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol Biol Cell 2006; 17: 4675-85.
24. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N,. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
25. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J,. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2723-43.
26. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG,. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.
27. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J,. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094-105.
28. Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao X, Zheng Y, Fan D,. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. Int J Cancer 2006; 118: 2965-72.
29. Rihet S, Vielh P, Camonis J, Goud B, Chevillard S, de Gunzburg J,. Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors. J Cancer Res Clin Oncol 2001; 127: 733-8.
30. Catherine F,. Welsh. Rho GTPases as key transducers of proliferative signals in G1 cell cycle regulation. Breast Cancer Res Treat 2004; 84: 33-42.
31. Jaffe AB, Hall A,. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-69.
32. Jaffe T, Schwartz B,. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 2008; 123: 2543-56.